UTI Healthcare Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 27-01-2023

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
UTI Healthcare Fund - Regular Plan - Growth Option -2.73 -4.25 -7.55 17.91 9.74 16.53
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P BSE Health Care - TRI -2.21 -4.64 -3.24 17.30 9.26 13.16

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 -7.55 17.91 9.74 2.56 691.46
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 -3.50 20.89 13.47 2.06 4,563.40
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 -0.07 21.17 10.79 2.14 1,660.46
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 -2.61 19.43 12.47 2.50 515.73

Fund Holdings as on 31-December-2022

  • EQ - SUN PHARMACEUTICALS INDUSTRIES

  • EQ - CIPLA LTD.

  • EQ - DR REDDYS LABORATORIES LTD.

  • EQ - APOLLO HOSPITALS ENTERPRISE LT

  • EQ - FORTIS HEALTHCARE LTD.

  • EQ - KRISHNA INSTITUTE OF MEDI SCIE

  • EQ - AJANTA PHARMA LTD.

  • EQ - ZYDUS LIFESCIENCES LTD

  • EQ - DIVIS LABORATORIES LTD.

  • EQ - IPCA LABORATORIES LTD.

  • EQ - ERIS LIFESCIENCES LTD

  • EQ - AUROBINDO PHARMA LTD.

  • EQ - SUVEN PHARMACEUTICALS LTD

  • EQ - TORRENT PHARMACEUTICALS LTD.

  • EQ - ABBOTT INDIA LTD.

  • EQ - GLAND PHARMA LTD.

  • EQ - ALKEM LABORATORIES LTD

  • NET CURRENT ASSETS

  • EQ - J.B.CHEMICALS & PHARMACEUTICAL

  • EQ - METROPOLIS HEALTHCARE LTD

  • EQ - POLY MEDICURE LTD

  • EQ - AMI ORGANICS LTD

  • EQ - PROCTOR & GAMBLE HEALTH LTD

  • EQ - INDOCO REMEDIES LTD.

  • EQ - RAINBOW CHILDRENS MEDICARE LTD

  • EQ - WINDLAS BIOTEC LTD

  • EQ - BIOCON LTD.

  • EQ - LUPIN LTD.

  • EQ - PFIZER LIMITED

  • EQ - ALEMBIC PHARMACEUTICALS

  • EQ - SANOFI INDIA LTD.

  • EQ - SEQUENT SCIENTIFIC LTD

  • EQ - SYNGENE INTERNATIONAL LTD.

  • 364 D TBILL MAT - 01/06/2023

  • CLEARING CORPORATION OF INDIA LTD. STD - MARGIN

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Medical Equipment/Supplies/Accessories

View More

Fund Manager

  • Cash

  • Equity

  • SOV

View More

About UTI Healthcare Fund

Scheme Analysis

UTI Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to UTI Mutual Fund. It was launched on 01-Aug-2005 and currently has an AUM of ₹691.46 crore. UTI Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care - TRI as secondary index.

The NAV of UTI Healthcare Fund ended up ₹0.32(0.22%)yesterday to ₹145.7138.

Among its top 3 holdings the fund has exposure to EQ - SUN PHARMACEUTICALS INDUSTRIES, and

The UTI Healthcare Fund is managed by V. Srivatsa and Kamal Gada.

Fund House Contact

UTI Towers, Gn Block, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 66786666
service@uti.co.in
+91 (22) 66786503,56786578
www.utimf.com